Presence of a reversible inhibitor(s) for human lymphoid cell RNA, protein, and DNA synthesis in the extracts of established human lymphoid cell lines.
D002250:Carbon Radioisotopes; D002460:Cell Line; D002464:Cell Migration Inhibition; D002474:Cell-Free System; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis*; D003851:Deoxyribonucleases; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007244:Infectious Mononucleosis / Q000276:immunology; D037102:Lectins; D007930:Leucine / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000276:immunology*; D008233:Lymphotoxin-alpha; D009132:Muscles / Q000276:immunology; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis*; D012867:Skin / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014020:Tissue Extracts / Q000494:pharmacology*; D014316:Tritium; D014357:Trypsin; D014529:Uridine / Q000378:metabolism
D002250:Carbon Radioisotopes; D037102:Lectins; D008233:Lymphotoxin-alpha; D014020:Tissue Extracts; D014316:Tritium; D012313:RNA; D004247:DNA; D003851:Deoxyribonucleases; D014357:Trypsin; D007930:Leucine; D013936:Thymidine; D014529:Uridine